dr. petrylak explains prostate cancer clinical trial difficulties
Published 13 years ago • 233 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
0:47
dr. daniel petrylak describes the clinical investigation of prostvac in prostate cancer
-
1:43
dr. petrylak discusses sequencing prostate cancer therapies
-
0:34
dr. petrylak discusses custirsen as a potential treatment for prostate cancer
-
0:47
dr. petrylak on the recent developments in prostate cancer
-
1:08
dr. daniel petrylak explains the correlation between immune response to sipuleucel-t and survival
-
1:43
dr. petrylak on imaging approaches in prostate cancer
-
11:57
#prostatecancer clinical trials: the benefits and risks | #markscholzmd #pcri
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
6:57
imaging goals and clinical trials for stage m0 prostate cancer
-
52:45
prostate cancer | daniel p petrylak, md
-
0:34
daniel petrylak, md, explains the effect of second antigen spread in mcrpc patients
-
1:23
dr. petrylak on a phase ii trial of psma adc in taxane-treated mcrpc
-
1:55
dr. petrylak discusses psma-directed therapies in prostate cancer
-
1:27
dr. petrylak on pivotal parp inhibitor trials in mcrpc with dna repair mutations
-
1:18
dr. petrylak on the role of psa screening in prostate cancer
-
5:32
clinical trial challenges in metastatic crpc
-
6:42
dr. shore on clinical trial challenges
-
1:22:50
demystifying prostate cancer clinical trials